BetterLife Pharma Inc.

OTC:BETRF

Pharmaceutical Preparations·VANCOUVER, A1

Summary Financials

Revenue

—

Adj. EBITDA

-$6.0M

FY 2018

Net Income

-$6.3M

FY 2018

EPS (Diluted)

-$0.10

FY 2016

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$71,639

FY 2018

Total Debt

$200,000

FY 2018

Net Debt

$128,361

FY 2018

Enterprise Value

—

Debt / EBITDA

-0.0x

FY 2018

EV / EBITDA

—

Employees

—

Revenue

—

Adj. EBITDA

-$6.0M

FY 2018

Net Income

-$6.3M

FY 2018

EPS (Diluted)

-$0.10

FY 2016

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$71,639

FY 2018

Total Debt

$200,000

FY 2018

Net Debt

$128,361

FY 2018

Enterprise Value

—

Debt / EBITDA

-0.0x

FY 2018

EV / EBITDA

—

Employees

—